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Measles virus (MV) infection in brain tissue of a patient with measles inclusion body
encephalitis wascharacterized by immunologic and biochemicaltechniques. Of the five
major structural proteins of MV, only nucleocapsid(N) protein and phosphoprotein (P
protein) were consistently detected in diseased brain areas. In contrast, hemagglutinin
protein was seen only occasionally, and no membrane and fusion proteins were found
in any of the sections studied. Messenger RNAs (mRNAs) specific for these five viral
proteins weredetected in all brain extracts examined; however, the mRNAs for the enve-
lope proteins were clearly underrepresented in comparison with lytically infected cells.
Only the mRNAs for Nand P proteins appeared active in in vitro translations. These
findings indicate quantitative differences in the pattern of mRNA expression in brain
tissue and a restricted expression of MV envelope proteins in infected cells as observed
in subacute sclerosing panencephalitis.
Measles inclusion body encephalitis (MIBE) is an
opportunistic infection occurring as a severe com-
plication of acute measles in immunodeficient indi-
viduals [1]. Frequently associated with malignancy
of the lymphatic or reticuloendothelial system, this
CNS disease has several similarities to subacute
sclerosing panencephalitis (SSPE). Neuropatholog-
icallesions found in MIBE consist of Cowdry type
A inclusion bodies in neurons and glial cells, nerve
cell loss, gliosis, diffuse and nodular proliferation
of microglia, and perivascular round cell infiltra-
tions. By electron microscopy, nucleocapsid (N)
structures of paramyxoviruses can be seen located
mainly in the cytoplasm of infected cells. No bud-
ding viruses or released particles of virus have been
observed, and only occasionally has infectious vi-
rus been isolated [2]. However, several clinical and
immunologic differences exist between MIBE and
SSPE. The incubation period between acute mea-
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sles and the onset of MIBE is much shorter than that
in SSPE. MIBE has a course of a few days to a few
weeks, whereas SSPE usually lasts for many years.
Subjects with MIBE demonstrate a reduced antibody
response to measles virus (MV), in contrast to the
hyperimmune reaction in SSPE.
In view of the immunodeficient state, it is surpris-
ing that this opportunistic infection of the CNS does
not lead to acute encephalitis with the synthesis of
infectious MV, as is seen in experimental infections
[3, 4]. Conceivably the replication of MV in brain
tissue may be defective, as in SSPE. This interpreta-
tion is supported by the observation that in some
cases of MIBE no antibodies to MV membrane (M)
protein are found, whereas the humoral immune re-
sponse to other viral structural proteins can be
demonstrated.
In this study we characterized the virus-cell inter-
action in brain tissue from a patient with MIBE.
RNA was isolated from the brain and analyzed by
both northern blot hybridization with strand-specific
riboprobes derived from parts of the six MV genes
and by the ability of the messenger RNAs (mRNAs)
to direct the synthesis of viral proteins in vitro. In
addition, the presence of five major structural pro-
teins of MV was assessed in infected brain tissue with
a panel of monoclonal antibodies by using immuno-
histological techniques. The observed defects in repli-
cation of MV virus in MIBE were compared with
those described in SSPE [5-8].
MV Gene Expression in MIBE
Materials and Methods
Patient. The clinical course and the pathologi-
cal findings have been described in detail [9]. A
22-mo-old girl was diagnosed as having acute
lymphoblastic leukemia by bone marrow aspiration.
Treatment with various immunosuppressive drugs in-
duced remission of the malignancy, but the further
course was complicated by development of acute
measles at the age of 41 mo. Two months later a CNS
disease with seizures developed, which progressed
to a comatose state and status epilepticus. The girl
died four months later. Pathological examination of
the brain revealed severe cortical necrosis with few
surviving neurons and massive infiltration of mac-
rophages. Eosinophilic inclusion bodies, which con-
sisted of paramyxovirus N structures, were detect-
able. There was no evidence of budding virus. In
numerous attempts, isolation of virus was unsuccess-
ful. The patient's serum contained antibodies to MV
hemagglutinin (H), fusion (F), and N proteins. In
the CSF, only antibodies to N protein were found.
Tissueprocessing. Brain tissue from our patient
was obtained shortly after death, immediately fro-
zen, and stored - 70 C.
Immunofluorescence. For evaluation of in vivo
synthesis of MV proteins and determination of the
relative frequency of the MV proteins present in brain
cells, a double-labeling indirect immunofluorescence
technique was used [8]. Serial, 6-llm-thick, frozen
sections were cut from several brain regions, fixed
in acetone for 20 min at - 20 C, and then incubated
with pooled monoclonal antibodies to different epi-
topes of MV structural proteins: phosphoprotein (P
protein), M, F, H, and biotinylated antibodies to N.
The sources of the antibodies were our laboratory
[10, 11], Dr. E. Norrby (Karolinska Institute, Stock-
holm) [12, 13], and Dr. T. A. Sato (National Insti-
tute of Health, Tokyo) [14]. FITC-conjugated anti-
bodies to mouse immunoglobulins and avidin-Texas
red were subsequently applied. Sections were washed
and mounted in glycerol. The number of cells ex-
hibiting specific labeling with the different mono-
clonal antibodies and their relative frequency were
determined by using a fluorescence microscope
(Leitz, Wetzlar, FRG).
Extraction of RNA. RNA was extracted from
frozen brain tissue [6]. Samples from different brain
regions were disrupted mechanically and homoge-
nized in guanidinium isothiocyanate buffer, and the
RNA was pelleted by centrifugation through cesium
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chloride. The pellet was dissolved in guanidinium hy-
drochloride, reprecipitated in ethanol, and finally
dissolved in 100mMNaCl, 1mMEDTA, and 10mM
HEPES (pH 7.0). The mRNAs were selected by
oligo-dthymidine chromatography.
Northern blots. MV-specific RNAs were ana-
lyzed as described previously [6, IS]. Ten micrograms
of total RNAs isolated from infected HeLa cells or
MIBE brain tissue was loaded onto a broad slot of
a 1.2070 agarose-formaldehyde gel together with a
mixture of standard RNAs synthesized in vitro con-
taining segments of MV mRNA species [16]. After
electrophoresis, the RNA was blotted onto nitrocel-
lulose paper, which was cut into strips. Sets with one
strip of each blot and one strip from a blot contain-
ing 4 fmol of each standard RNA exclusively (exter-
nal standards) were then hybridized in the same bag
with a 32P-labeled RNA probe of one of the MV
genes [16]. After autoradiography of the strips, the
bands corresponding to the MV mRNAs and to the
internal and external standards were cut out, and the
amount of radioactivity bound was determined.
In vitro translation and immunoprecipitation.
The ability of the different MV mRNAs to direct
the synthesis of the respective proteins was inves-
tigated using an in vitro translation system [6]. Prod-
ucts made in vitro were immunoprecipitated using
a polyclonal rabbit antiserum to MV and monospe-
cific antisera to P, H, N, and M proteins. The total
translate and the immunoprecipitated proteins were
analyzed by 10070 SOS-PAGE [5]. Attempts to iden-
tify F protein were unsuccessful, because none of
the available monospecific or monoclonal antibod-
ies to F protein were able to detect it in in vitro trans-
lation reactions using mRNAs from Vero cells lyti-
cally infected with MV.
Results
Detection of MV structural proteins in infected
brain tissue by immunohistology. To assess the
presence of MV structural proteins in infected brain
cells, we incubated cryostat-cut brain sections with
a panel of monoclonal antibodies to five structural
proteins (N, P, M, F, and H) of MV. The antibody
used reacted with different epitopes of each struc-
tural protein. Nand P proteins were easily visual-
ized in brain cells, whereas H protein could only oc-
casionally be seen (table 1). In contrast, M and F
proteins could not be detected in any area or section
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Table 1. Detection of MV structural proteins in brain
cells by double-labeling immunofluorescence.
NOTE. Monoclonal antibodies reacting with the respective
proteins were pooled as described previously [8]. Positive cells
were counted in 10 visual fields from three different brain
regions - cerebral cortex, white matter, and cerebellum - using
a x 40 objective. The percentage of cells positive is given rela-
tive to reactivity for N protein.
tested, independent of the monoclonal antibody
used.
The fluorescence patterns of the three detectable
MV structural proteins differred. Monoclonal anti-
bodies to MV N protein gave the most widespread
fluorescent staining in the cytoplasm of the cellular
processes of the cell bodies, as well as within inclu-
sion bodies of oligodendrocytes, astrocytes, and neu-
rons (figure I, top). Monoclonal antibodies to P
protein gave a strong fluorescent staining that was
similar in appearance to the staining for N protein,
except that no nuclear inclusion bodies were stained
(data not shown). In contrast, monoclonal antibod-
ies to H protein resulted in a weak, diffuse fluores-
cence of the cytoplasm (figure I, bottom).
Analysis ofMV mRNAs in brain tissue by north-
ern blots. Total RNA derived from brain tissue of
the patient with MIBE and MV-infected HeLa cells
was analyzed for the presence of virus-specific RNAs
by northern blots using riboprobes of negative-
strand polarity derived from fiveMV genes [16]. Lyti-
cally infected HeLa cells contained all six MV
mRNAs (figure 2A). Those for N, P, M, F, and H
appear as strong bands. The bands of weaker inten-
sity represent bicistronic and tricistronic transcripts
of adjacent genes [6]. The two bands in figure 2A,
lane M - one above the M mRNA and the other be-
tween the M-F and M-F-H polycistronic RNAs-
result from cross-hybridization of the GC-rich probe
with 18Sand 28S ribosomal RNA [16]. Owing to the
longer exposure, the intensity of these bands is
stronger in figure 2B. Total RNA isolated from brain
tissue of the patient with MIBE reacted strongly with
the Nand P probes (figure 2B). However, the
amounts of the M, F, and H mRNAs are significantly
reduced in comparison with Iytically infected cells.
In addition, a band of weak intensity migrating more
slowly than the 16-kilobase genome, is detected in
figure 2B, lanes N, P, and M. This band could rep-
resent a "copy-back" defective genome, containing
only the N, P, and M genes, that migrates slowly be-
cause of an extensive double helical structure. The
amount of the M-F bicistronic transcript is increased
(figure 2B, lanes M and F). This increment is accom-
Figure 1. Indirect immunofluorescence using pooled
monoclonal antibodies to Nand H proteins of MV. Top,
numerous cells stain for N protein. Cell processes reveal
granular staining (bar = 30 11m); and inclusion bodies (in-
set) are also strongly positive (bar = 11 11m). Bottom,
fluorescence for the H protein is weak and diffuse, re-
stricted to single cells (bar = 20 11m).
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Figure 2. Northern blotanalysis of six MV-specific tran-
scripts: (A) with totalRNAderived fromlytically infected
HeLacells and (B) withtotal RNAderived frombraintis-
suefroma patientwithMIBE. In bothcases 10 ugof total
RNA was loaded onto a broad slot of a 1.2% agarose-
formaldehyde gel together with a mixture of standard
RNAs [16] synthesized in vitro (1.0 fmol of each stan-
dard in A and 0.1 frnol for B) and containing segments
ofMV mRNA species (e). Afterelectrophoresis, the RNA
was blottedonto nitrocellulose, which was cut into strips.
Strips were thenhybridized withdifferent 32P-Iabeled RNA
probesderived from the sameplasmids as the unlabeled
standards [16]. Themonocistronic mRNAs (<1), the bicis-
tronicRNAs (. ), and the tricistronic RNAs (0) areindi-
cated. The lengths of the N internal standard (0.67 kilo-
bases), the N mRNA(1.8 kilobases), the N-P bicistronic
RNA (3.5 kilobases), and the genome (16 kilobases) are
indicated to the left of lane N. Ori = origin.
panied, as expected, by a reduction in the amount
of P-M and M-F bicistronic transcripts (not detect-
able) and by enhancement of the M-F-H tricistronic
transcript.
To quantitate the data presented in figure 2B, we
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Table 2. Copy numbers of MV transcripts per 10 pg
of total RNA.
MIBE
Transcript HeLa cells brain tissue
N 30000 4500
P 9000 1400
M 9500 180
F 5500 60
H 4000 30
L 500 <;;;15
M-F 600 150
Standard 600 60
NOTE. After exposure of the northern blots, bands cor-
responding to theMY transcripts and to theinternal standards
were cut out, and the amount ofradioactivity bound was deter-
mined. The quantities of MY transcripts were related to 10 pg
of total RNA, which isthe RNA content ofanaverage cultured
HeLa cell [16].
determined the amount of radioactivity of the differ-
ent mRNAs in relation to the internal standard in-
cluded in the assay (seethe lower bands, marked with
a dot, in each track of figure 2). The number ofMV-
specific transcripts, in brain tissue, involving mainly
M, F, and H genes drops drastically in comparison
with lytically infected HeLa cells (table 2). The
amount of M-F bicistronic RNA is relatively high,
equaling that of M mRNA and exceeding that of
F mRNA.
In vitro translation reactions of isolated brain
mRNAs. To test the biologic activity of the MV
mRNAs present in the brain and to determine their
ability to direct the synthesis of the corresponding
proteins, we used an in vitro translation procedure
to detect such synthesis. Only Nand P proteins are
synthesized, whereas M protein is not made, despite
the presence of its mRNA (figure 3). In addition,
no H protein is synthesized in the in vitro transla-
tion reaction; this lack of synthesis may result from
the low concentration of mRNA, as observed in the
northern blot. It is not possible to make any state-
ment about the F protein because we could not de-
tect it in control in vitro translation experiments
using mRNAs from lytically infected cells [6].
Discussion
Our immunohistochemical and biochemical results
indicate that MV persistence in brain cells from an
individual with MIBE is characterized by the restric-
tion of expression of three viral genes. In infected
brain cells, only the Nand P proteins of MV are con-
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Figure 3. In vitro translation of mRNAs derived from
control brain (CB), lytic MY (MV), or brain tissue from
a patient with MIBE (MIBE). The products synthesized
were either analyzed directly (I) or after immunoprecipi-
tation in 10070 SDS-PAGE. rb, Immunoprecipitation with
rabbit hyperimmune antiserum to MY; P, H, N, and M,
immunoprecipitations with specific antisera.
sistently detected, and only the mRNAs of these two
proteins are biologically active in an in vitro trans-
lation system. The expression of the H protein is re-
duced, whereas M and F proteins were not detect-
able in brain cells, despite the presence of their
corresponding mRNAs. In part, this situation could
be the result of the low concentrations of the
mRNAs, particularly those for F and H proteins,
which are significantly reduced when compared with
values in lytically infected cells. However, because
M protein is not formed either in vivo or in vitro,
although M mRNA is present in greater amounts
than H mRNA, it seems likely that M mRNA is non-
functional. A relatively large amount of M-F bicis-
tronic RNA is found, an observation suggesting that
the polymerase often does not recognize correctly
the processing signal at the M-F intercistronic region.
These findings are similar to previous observations
made in SSPE. In this slow virus disease the synthe-
sis of MV structural proteins in infected brain cells
is also highly variable. As in MIBE, Nand P pro-
teins are consistently detected in each area of brain
examined from individuals with SSPE, whereas H,
F, and M proteins were either reduced in amount or
absent [8,12]. The results of the biochemical analy-
sis of MV gene expression in brains showing SSPE
are rather complex [5-7, 15].Generally the mRNAs
coding for MV N, P, and M proteins are easily de-
tectable in brain tissues, whereas those for Hand
F proteins are strongly reduced in amount when com-
pared with values in lytically infected cells.Although
the amounts of viral mRNA within different parts
of the same brain varied, the ratio of individual
mRNAs remained constant. However, only the
mRNAs for the N protein consistently directed syn-
thesis of this polypeptide in in vitro translation sys-
tems, whereas P protein synthesis was detected in
750/0 ofthe subjects studied, and electrophoretic mo-
bility shifts wereencountered. Attempts to detect H
protein in in vitro translations by using mRNA iso-
lated from infected brain tissue were unsuccessful,
either as a result of the relatively low concentration
of this mRNA or of functional defects of the tran-
script. Of particular interest are the results obtained
for M protein. Despite the presence of intermediate
levels of M mRNA in infected brain tissue in most
of the cases studied, no in vitro product of this
mRNA could be detected [6]. This translation de-
fect of the M mRNA was further analyzed in one
case. The sequence analysis of the M gene revealed
severaldifferences from the Edmonston strain M se-
quence [17]. In particular, one base substitution was
observed that created a stop codon at position 12
of the M-gene reading frame, an observation explain-
ing why the M protein could not be synthesized [17].
The lack of synthesis of MV envelope proteins
could explain the failure to observe budding parti-
cles of virus and to isolate infectious virus from
brains of individuals with MIBE. There is apparently
no need for production of infectious particles of vi-
rus to perpetuate the infectious process in MIBE as
in SSPE, because the MV nucleocapsid alone is in-
fectious. In tissue culture experiments, isolated N
structures - consisting of viral RNA and three viral
structural proteins, L, P, and N- represent the rep-
licative complex and are sufficient for maintaining
viral replication in transfection experiments [18].
Therefore restriction of the expression of the MV
envelope gene is not strictly deleterious to the sur-
vival of the persisting virus in brain tissue and may
actually enable the virus to escape immune surveil-
lance. For effectiveelmination of virus-infected cells,
immune effector cells must recognize the viral struc-
tural proteins on the cellsurface. In SSPE and MIBE,
most infected brain cells do not demonstrate viral
envelope proteins because these proteins are synthe-
sized at very low levels if at all. Therefore infected
brain cells can escape immune surveillance, and the
MV Gene Expression in MIBE
replicative complex of MV can be spread in the CNS
by means of cell-to-cell transport via cell processes.
Although our findings shed some light on the
mechanisms of MV persistence in human brain tis-
sue, they do not delineate which factors are involved
in the establishment of persistence and how the ob-
served replication defects develop. Antibody-induced
antigenic modulation of MV-infected cultured cells
leads to persistence and affects viral replication [19].
Antibodies to MV remove viral glycoproteins from
the surface of infected cells and reduce expression
of some intracellular viral polypeptides. A marked
perturbation of levels of the P and M proteins was
observed when polyclonal antibody to MV was
added to infected cultures. This mechanism may con-
tribute to establishment of MV persistence in SSPE,
where an immune defect has not been detected [20].
In MIBE, however, MV infection of brain tissue oc-
curs in individuals with severe immunodeficiency,
who are unable to respond properly to the infectious
agent. In this disease, additional factors obviously
interfere with MV replication in CNS tissue.
We observed recently that levels of the envelope
proteins of MV are significantly reduced in infected
brain cells of suckling Lewisrats at the onset of acute
measles encephalitis [3]. This reduction in synthesis
of MV proteins points to a rapid development of a
defective multiplication cyclefor the virus in rat brain
in the absence of a measurable immune response.
This observation suggests that factors independent
of the immune system, probably specific for CNS
cells, interfere with viral replication. Little is known
about such factors, but in recent in vitro studies with
papaverine, transcription of MV RNAs was in-
hibited, and a selectivesuppression of M protein syn-
thesis occurred in neural cells [21,22]. Many factors
are clearly involved in controlling MV replication in
brain tissue, and these factors determine whether an
adventitious infection without further consequences
ensues or a threat to the host with expression of al-
tered viral genes and initiation of a pathological pro-
cess is triggered.
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